Collectively, lipid droplet associated proteins can be explored for therapeutic intervention strategies, and the cell culture models proofs to be valuable for an identification of putative targets and an evaluation of drug candidates for the treatment of NAFLD. The gene discussed is PLIN1; the disease is metabolic dysfunction-associated steatotic liver disease.